BULLOUS PEMPHIGOID
Clinical trials for BULLOUS PEMPHIGOID explained in plain language.
Never miss a new study
Get alerted when new BULLOUS PEMPHIGOID trials appear
Sign up with your email to follow new studies for BULLOUS PEMPHIGOID, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-Dose hope for blistering skin disease?
Disease control CompletedThis study tested whether a single cycle of the drug rituximab can control bullous pemphigoid, a painful blistering skin condition. Researchers followed 18 adults for up to two years to see if the drug stopped the disease and checked for side effects. The goal was to find a treat…
Matched conditions: BULLOUS PEMPHIGOID
Phase: PHASE3 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated May 17, 2026 07:04 UTC
-
New shot could tame blistering skin disease and cut steroid use
Disease control CompletedThis study tested a drug called efgartigimod in 98 adults with moderate to severe bullous pemphigoid, a condition that causes painful blisters and itching. The goal was to see if the drug could help people achieve complete remission (no new blisters, healed skin, no itching) whil…
Matched conditions: BULLOUS PEMPHIGOID
Phase: PHASE2, PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated May 17, 2026 07:01 UTC
-
New combo therapy for blistering skin disease may be easier and safer
Disease control CompletedThis study tested whether adding methotrexate to topical steroids for bullous pemphigoid works as well as using topical steroids alone. 322 adults with the disease took part. The goal was to see if the combination treatment is equally effective but easier to manage and with fewer…
Matched conditions: BULLOUS PEMPHIGOID
Phase: PHASE3 • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated May 17, 2026 06:50 UTC
-
New drug combo may calm painful blisters in elderly skin disease
Disease control CompletedThis study tested whether adding avdoralimab (an antibody that blocks a specific immune signal) to strong steroid creams helps people with bullous pemphigoid, a blistering skin disease common in people over 70. Fifteen participants received the combination, and researchers measur…
Matched conditions: BULLOUS PEMPHIGOID
Phase: PHASE2 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated May 17, 2026 06:48 UTC
-
New drug shows promise for rare blistering skin condition in older adults
Disease control CompletedThis study tested whether dupilumab, a drug that calms the immune system, can safely treat bullous pemphigoid—a painful blistering skin disease that mostly affects people over 60. About 106 adults took part. The goal was to see if dupilumab could help patients stop taking steroid…
Matched conditions: BULLOUS PEMPHIGOID
Phase: PHASE2, PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Steroid cream surprise: study probes hidden fluid shifts in skin disease
Knowledge-focused CompletedThis study looked at whether a very strong steroid cream (clobetasol propionate) causes fluid retention in 30 adults with bullous pemphigoid, a blistering skin condition. Researchers measured changes in body water using a special scale (bioimpedance) over 30 days. The goal was to…
Matched conditions: BULLOUS PEMPHIGOID
Phase: PHASE4 • Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated May 13, 2026 16:01 UTC